Zobrazeno 1 - 10
of 420
pro vyhledávání: '"Lesley H Curtis"'
Autor:
Catherine A Panozzo, Lesley H Curtis, James Marshall, Lawrence Fine, Barbara L Wells, Jeffrey S Brown, Kevin Haynes, Pamala A Pawloski, Adrian F Hernandez, Sarah Malek, Beth Syat, Richard Platt
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0223515 (2019)
BackgroundData from randomized controlled trials and observational studies on older adults who take statins for primary prevention of atherosclerotic cardiovascular disease are limited. To determine the incidence of statin use in older adults with an
Externí odkaz:
https://doaj.org/article/7943cfdd0ff84a6a88d4f62860405c01
Autor:
Joseph AC Delaney, Xiaoyan Yin, João Daniel Fontes, Erin R Wallace, Asheley Skinner, Na Wang, Bradley G Hammill, Emelia J Benjamin, Lesley H Curtis, Susan R Heckbert
Publikováno v:
SAGE Open Medicine, Vol 6 (2018)
Background: Atrial fibrillation is increasingly prevalent as the US population ages and is associated with significant morbidity and mortality. Care for patients with atrial fibrillation can be costly, US health care costs are comparatively high, and
Externí odkaz:
https://doaj.org/article/73b698a473d94983a5f3fb1df37fa252
Autor:
Matthew L Maciejewski, Bradley G Hammill, Corrine I Voils, Laura Ding, Elizabeth A Bayliss, Lesley H Curtis, Virginia Wang
Publikováno v:
SAGE Open Medicine, Vol 6 (2018)
Background: Many older adults have multiple conditions and see multiple providers, which may impact their use of essential medications. Objective: We examined whether the number of prescribers of these medications was associated with the availability
Externí odkaz:
https://doaj.org/article/5864f3640a1748e09d49fa69d49acbc4
Autor:
Emily C. O’Brien, Jeremy Sugarman, Kevin P. Weinfurt, Eric B. Larson, Patrick J. Heagerty, Adrian F. Hernandez, Lesley H. Curtis
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background The COVID-19 pandemic has considerably disrupted nearly all aspects of daily life, including healthcare delivery and clinical research. Because pragmatic clinical trials are often embedded within healthcare delivery systems, they
Externí odkaz:
https://doaj.org/article/c230e6f10eb74b55a2d00af87199f31f
Autor:
Stephen J. Greene, Sujung Choi, Steven J. Lippmann, Robert J. Mentz, Melissa A. Greiner, N. Chantelle Hardy, Bradley G. Hammill, Nancy Luo, Marc D. Samsky, Paul A. Heidenreich, Warren K. Laskey, Clyde W. Yancy, Pamela N. Peterson, Lesley H. Curtis, Adrian F. Hernandez, Gregg C. Fonarow, Emily C. O'Brien
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 16 (2021)
Background Sacubitril/Valsartan has been highly efficacious in randomized trials of heart failure with reduced ejection fraction (HFrEF). However, the effectiveness of sacubitril/valsartan in older patients hospitalized for HFrEF in real‐world US p
Externí odkaz:
https://doaj.org/article/8ad63756201b4343b8982dad3a51571f
Autor:
Nancy Luo, Steven J. Lippmann, Robert J. Mentz, Melissa A. Greiner, Bradley G. Hammill, N. Chantelle Hardy, Warren K. Laskey, Paul A. Heidenreich, Chun‐Lan Chang, Adrian F. Hernandez, Lesley H. Curtis, Pamela N. Peterson, Gregg C. Fonarow, Emily C. O'Brien
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 3 (2019)
Background The angiotensin‐receptor/neprilysin inhibitor (ARNI) sacubitril/valsartan reduces hospitalization and mortality for patients with heart failure with reduced ejection fraction. However, adoption of ARNI into clinical practice has been slo
Externí odkaz:
https://doaj.org/article/37c7bb1a3b0545be89b2b4419d4676c5
Autor:
Jeffrey D. Clough, Seth S. Martin, Ann Marie Navar, Li Lin, N. Chantelle Hardy, Ursula Rogers, Lesley H. Curtis
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 3 (2019)
Background The 2013 American College of Cardiology/American Heart Association Cholesterol Treatment Guideline increased the number of primary prevention patients eligible for statin therapy, yet uptake of these guidelines has been modest. Little is k
Externí odkaz:
https://doaj.org/article/2dd33799fc4f42aab4b1072f2c86de53
Autor:
Oriol Sola‐Morales, Lesley H. Curtis, Julien Heidt, Laura Walsh, Deborah Casso, Susan Oliveria, Patrick Saunders‐Hastings, Yufei Song, Tiffany Mercado, Robbert Zusterzeel, Vera Mastey, James Harnett, Ruben G. W. Quek
Publikováno v:
Clinical Pharmacology & Therapeutics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9aa13f93bb730ef74df9e0d1ce175dc2
https://doi.org/10.1002/cpt.2914
https://doi.org/10.1002/cpt.2914
Autor:
Lesley H. Curtis, Oriol Sola‐Morales, Julien Heidt, Patrick Saunders‐Hastings, Laura Walsh, Deborah Casso, Susan Oliveria, Tiffany Mercado, Robbert Zusterzeel, Rachel E. Sobel, Jessica J. Jalbert, Vera Mastey, James Harnett, Ruben G. W. Quek
Publikováno v:
Clinical Pharmacology & Therapeutics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::545c6804b3dd92d18dd88fcab40dfa67
https://doi.org/10.1002/cpt.2913
https://doi.org/10.1002/cpt.2913
Autor:
Sudha R Raman, Emily C O’Brien, Bradley G Hammill, Adam J Nelson, Laura J Fish, Lesley H Curtis, Keith Marsolo
Publikováno v:
J Am Med Inform Assoc
Objective To empirically explore how pragmatic clinical trials (PCTs) that used real-world data (RWD) assessed study-specific fitness-for-use. Methods We conducted interviews and surveys with PCT teams who used electronic health record (EHR) data to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41af8580a5347fa11c2045f6c729e76e
https://doi.org/10.1093/jamia/ocac004
https://doi.org/10.1093/jamia/ocac004